HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype.

Abstract
We report the successful management of a case of hemolytic disease and hydrops fetalis secondary to anti Rh 17 antibodies in a woman with the rare D-- phenotype. We discuss the efficacy of intravenous immunoglobulins in treating hemolytic disease of the newborn infant.
AuthorsK Aref, F N Boctor, S Pande, J Uehlinger, F Manning, M Eglowstein, A Mallozzi, M Bebbington, G Weinberg, O Rosen, C Raab, L P Brion
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 22 Issue 8 Pg. 667-8 (Dec 2002) ISSN: 0743-8346 [Print] United States
PMID12478452 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Rh-Hr Blood-Group System
  • Rho(D) antigen
Topics
  • Adult
  • Erythroblastosis, Fetal (etiology, genetics, therapy)
  • Female
  • Humans
  • Hydrops Fetalis (etiology, genetics, therapy)
  • Infant, Newborn
  • Phenotype
  • Pregnancy
  • Rh-Hr Blood-Group System (adverse effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: